<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-72242" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Pathophysiology Of Asthma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sinyor </surname>
            <given-names>Benjamin</given-names>
          </name>
          <aff>Aventura Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Concepcion Perez</surname>
            <given-names>Livasky</given-names>
          </name>
          <aff>Aventura Hospital and Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Benjamin Sinyor declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Livasky Concepcion Perez declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-72242.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Asthma is becoming a more prevalent disease since the early 1990s. From 1982 to 1992, the rate of asthma jumped from 34.7&#x000a0;to 49.4 per thousand.<xref ref-type="bibr" rid="article-72242.r1">[1]</xref>&#x000a0;The prevalence of asthma in the USA is around 8%.<xref ref-type="bibr" rid="article-72242.r2">[2]</xref>&#x000a0;There also has been some mixed trends around the world where different countries have either had increasing cases or have been stagnant.<xref ref-type="bibr" rid="article-72242.r3">[3]</xref>&#x000a0;In children, asthma is presented predominantly in males until the age of 20, where the disease equally prevalent. Differences in childhood can be due to atopy, or because boys have a reduced airway size compared to girls.<xref ref-type="bibr" rid="article-72242.r4">[4]</xref>&#x000a0;There is a family history component of asthma, as well. However, the genes responsible for inheriting asthma remain unidentified.&#x000a0;There are mechanisms of the phenotype of asthma that has a strong correlation of being inherited, but the mechanism is more complex, as asthma does not follow a Mendelian pattern. Asthma is most likely transmitted by multiple genes, with some variation of locus heterogeneity and polygenic inheritance leading to asthma expression being multifaceted. Atopy or IgE antibodies attack specific&#x000a0;antigens or pollutants, which can contribute to the disease. Research has shown that asthma was closely related to the total IgE serum level.<xref ref-type="bibr" rid="article-72242.r5">[5]</xref>&#x000a0;Enhanced IgE response to environmental factors such as house dust mites, animal allergens, mold, farm animals, have contributed to sensitize asthma exacerbating its symptoms and attributing to increased airway reactivity. The reason being is that there is increased exposure to these allergens, but less data is available on the causality.&#x000a0; Air pollution and the causation of asthma are also less clear; however, there is a relationship with smoking and the increased risk of asthma.<xref ref-type="bibr" rid="article-72242.r6">[6]</xref>&#x000a0;Interestingly enough, obesity showed a positive linear relationship between asthma and increased BMI.<xref ref-type="bibr" rid="article-72242.r7">[7]</xref>&#x000a0;More research needs to be done to have a clearer picture of the multifactorial disease.</p>
      </sec>
      <sec id="article-72242.s2" sec-type="Organ Systems Involved">
        <title>Organ Systems Involved</title>
        <p>The organ system affected by asthma is the lungs. The lungs consist of lobes and segments, with the right lung having ten segments and the left lung having eight or nine, depending on the division of the lobe.<xref ref-type="bibr" rid="article-72242.r8">[8]</xref>&#x000a0;Anatomically, the respiratory system falls into two zones, characterized by the conducting zone and the respiratory zone. The conducting zone extends from the nose to the bronchioles, and the respiratory zone where gas exchange takes place is from the alveolar duct to the alveoli.<xref ref-type="bibr" rid="article-72242.r9">[9]</xref>&#x000a0;Asthma is primarily involved in the bronchial tree, with its primary job to distribute air throughout the lungs until reaching the alveolar sacs. The bronchi stem from the end of the trachea, which divides into left and right bronchi. The right bronchus has a wider diameter and lies more vertically, while the left bronchus is smaller and more horizontal. The bronchi then divide into secondary and tertiary bronchi. The bronchi contain smooth muscle and elastic fibers to maintain their wall integrity, which change based on the contraction and relaxation of smooth muscle by inflammatory mediators, bronchoconstrictor, or bronchodilators.<xref ref-type="bibr" rid="article-72242.r10">[10]</xref>&#x000a0;As one progresses further from the bronchi to the alveoli, there are much more smooth muscle fibers involved.<xref ref-type="bibr" rid="article-72242.r9">[9]</xref>&#x000a0;In normal respiratory physiology, lung compliance is the willingness for the lungs to distend, while elastance is the ability of the lungs to return to their resting position. In patients with asthma, the physiologic mechanism changes due to inflammation, decreasing the radius of the airway.<xref ref-type="bibr" rid="article-72242.r11">[11]</xref>&#x000a0;All of these mechanisms together change the compliance of the lungs slightly to increase the work of breathing. &#x000a0;</p>
      </sec>
      <sec id="article-72242.s3" sec-type="Mechanism">
        <title>Mechanism</title>
        <p>There are two phases of an asthma exacerbation, which include the early phase and the late phase. The early phase is initiated by IgE antibodies that are sensitized and released by plasma cells. These antibodies respond to certain triggers in the environment, such as the risk factors listed above. IgE antibodies then bind to high-affinity mast cells and basophils. When a pollutant or risk factor gets inhaled, the mast cells release cytokines and eventually de-granulate. Released from mast cells are histamine, prostaglandins, and leukotrienes. These cells, in turn, contract the smooth muscle and cause airway tightening.<xref ref-type="bibr" rid="article-72242.r12">[12]</xref>&#x000a0;Th2 lymphocytes play an integral role where they produce a series of interleukins (IL-4, IL-5, IL-13) and GM-CSF, which aid in communication with other cells and sustain inflammation. IL-3 and IL-5 help eosinophils and basophils survive. IL-13 is involved in&#x000a0;remodeling, fibrosis, and hyperplasia.<xref ref-type="bibr" rid="article-72242.r13">[13]</xref>&#x000a0;Within the next several hours, the late phase occurs, in which eosinophils, basophils, neutrophils, and helper and memory T-cells all localize to the lungs as well, which perform bronchoconstriction and cause inflammation. Mast cells also play an essential role in bringing the late-phase reactants to the inflamed sites.<xref ref-type="bibr" rid="article-72242.r14">[14]</xref>&#x000a0;It is critical to recognize both of these two mechanisms to target therapy and relieve both bronchoconstriction and inflammation, depending on the severity of the disease. Interestingly, those with a thicker airway over time have a longer disease duration due to a narrower airway.<xref ref-type="bibr" rid="article-72242.r15">[15]</xref>&#x000a0;As a result of inflammation and bronchoconstriction, there is an intermittent airflow obstruction, resulting in increased work of breathing. &#x000a0;</p>
        <p>Airway hyperresponsiveness is a crucial feature of asthma; this is an exaggerated bronchoconstrictor response, usually to different stimuli. There are a variety of mechanisms leading to airway hyperresponsiveness. Some explanations are due to increased histamine from mast cells or increase airway smooth muscle mass. Also, there is an increased vagal tone and increased intracellular free calcium that further enhances airway smooth muscle cell contractility.<xref ref-type="bibr" rid="article-72242.r15">[15]</xref>&#x000a0;To assess airway hyperresponsiveness, bronchial provocation tests are used to determine the severity.<xref ref-type="bibr" rid="article-72242.r16">[16]</xref>&#x000a0;This aspect is clinically significant because the presence of airway hyperresponsiveness is associated with a greater decline in lung function and increased risk for the development and exacerbation of asthma from childhood to adulthood.<xref ref-type="bibr" rid="article-72242.r17">[17]</xref>&#x000a0;Therefore, targeted treatment can be employed early to combat asthma and hyperresponsiveness. All of these mechanisms together change the compliance of the lungs slightly to increase the work of breathing.&#x000a0; In combination with inflammation, granular white blood cells, exudate, and mucous occupying the bronchiolar trees, it can be increasingly difficult for a person to breathe normally. The number of myofibroblasts, which give rise to collagen, will cause an increase in the epithelium, which narrows the smooth muscle layer and lamina reticularis.<xref ref-type="bibr" rid="article-72242.r18">[18]</xref>&#x000a0;As a result, there is an increased thickening of the basement membrane. A person can have irreversible obstruction of airflow, which is believed to be due to airway remodeling.<xref ref-type="bibr" rid="article-72242.r19">[19]</xref></p>
        <p>Remodeling occurs by epithelial cells transitioning to mesenchymal, increasing the smooth muscle content. Epithelial cells lose their cell adhesion and functional polarity with tight junctions, reformatting their cells to develop into mesenchymal cells.<xref ref-type="bibr" rid="article-72242.r18">[18]</xref>&#x000a0;Additionally, eosinophils can further exacerbate airway remodeling due to their release of TGF-B and cytokines by interactions with mast cells. These mechanisms of airway remodeling may worsen inflammation and aggravate asthma over time if not treated and managed&#x000a0;correctly.<xref ref-type="bibr" rid="article-72242.r15">[15]</xref></p>
      </sec>
      <sec id="article-72242.s4" sec-type="Related Testing">
        <title>Related Testing</title>
        <p>To diagnose asthma, clinicians can do a variety of tests. Tests must determine: expiratory airflow limitation, documentation of reversible obstruction, and rule out any exclusion of an alternative diagnosis. Assessing the patient&#x02019;s obstruction via spirometry and checking for a reversible change after a bronchodilator is suggestive of the diagnosis of asthma. By using spirometry, physicians can diagnose asthma as well as the severity of obstruction.<xref ref-type="bibr" rid="article-72242.r20">[20]</xref>&#x000a0;The definition of the obstruction of air is spirometry of FEV1 less than 0.8, and the FEV1/FVC ratio is less than 0.70. The worse the asthma is, the lower the number is for FEV1 and the FEV1/FVC ratio.&#x000a0;Another method of testing, if spirometry is normal, is bronchoprovocation testing with methacholine. Methacholine is a muscarinic agonist, which in the lungs constricts smooth muscle via M1, M2, and M3 receptors.<xref ref-type="bibr" rid="article-72242.r21">[21]</xref>&#x000a0;Methacholine can determine the severity of bronchoconstriction.&#x000a0;Allergy testing is not necessarily useful in diagnosing asthma, but it can help identify certain triggers that worsen it.</p>
      </sec>
      <sec id="article-72242.s5" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Asthma can paint a slightly different clinical picture, and clinicians must identify them. Asthmatic patients can usually have but are not limited to, wheezing, shortness of breath, and a cough, which is often worse at night. There are various triggers that intensify asthma. Such triggers are cold air, exercise, and the pollutants listed above. Other non-specific symptoms that could suggest a severe obstruction can be tachypnea, tachycardia, or a patient seated in a tripod position.&#x000a0;Asthma can be a severe disease if not treated and managed correctly<bold>. </bold>Since there are two phases of asthma, it is essential to try to target and decrease bronchoconstriction, inflammation, and airway remodeling. Asthma is defined in different stages depending on spirometry and/or clinical indications. There are four stages regarding the severity of asthma, intermittent, mild, moderate, and severe. Depending on the specific stage of asthma, treatment and management change. Intermittent asthma occurs when one has symptoms less than&#x000a0;two days a week and nighttime awakenings less than&#x000a0;two times a month. Mild asthma consists of having episodes more than two days a week (but not daily), while there are nighttime awakenings of 3&#x000a0;to 4 times a month. Moderate asthma is where the patient is symptomatic daily and has nighttime awakenings greater than once a week but not nightly. Severe asthma is when a patient is symptomatic throughout the day and often has nighttime awakenings more than&#x000a0;seven times within a week. Based on these criteria, correct treatment can be administered to decrease the symptoms of the patient. The most common medications used are short-acting beta-agonists, long-acting beta-agonists, muscarinic antagonists, and inhaled and systemic glucocorticoids<bold>.</bold> The idea behind a beta-agonist is to try to bronchodilate the patient&#x02019;s lungs when they become constricted during an asthma attack. The mechanism behind beta-agonists is that they are G protein receptors that activate cAMP. cAMP then activates smooth muscle relaxation by a mechanism not fully understood. Also, a glucocorticoid may be used to decrease the inflammation and remodeling of the lungs. The primary mechanism of a glucocorticoid is to increase the production of IL-10. IL-10 inhibits inflammatory cytokines, T-cell activation, and different white cells such as mast cells and eosinophils.<xref ref-type="bibr" rid="article-72242.r22">[22]</xref>&#x000a0;These effects decrease inflammation and help the patient breathe better in the short and long term. Muscarinic antagonists block the inflammatory effect by diminishing the attraction and life of inflammatory cells, diminishing cytokine release.<xref ref-type="bibr" rid="article-72242.r23">[23]</xref>&#x000a0;Muscarinic antagonists can be paired with a beta-agonist or glucocorticoid for a synergistic effect.</p>
      </sec>
      <sec id="article-72242.s6">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=72242&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=72242">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/72242/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=72242">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-72242.s7">
        <fig id="article-72242.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Pathophysiology of Asthma. Figure A displays the location of the lungs and airways in the body. Figure B shows a cross section of a normal airway. Figure C illustrates a cross section of an airway during asthma symptoms National Institutes of Health</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Asthma_attack-illustration_NIH" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-72242.s8">
        <fig id="article-72242.image.f2" position="float" orientation="portrait">
          <caption>
            <p>A Chest Radiograph Depicting Asthma. The image depicts both anterior and lateral radiographs of a patient with asthma. The image highlights the presence of pneumomediastinum and increased bronchovascular markings. Contributed by H Shulman, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ASTH_2_PA_Lat" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-72242.s9">
        <fig id="article-72242.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Allergic Bronchopulmonary Aspergillosis on CT Scan. Computed tomography (CT) images reveal bronchiectasis in both upper lobes of a patient with bronchial asthma, indicative of allergic bronchopulmonary aspergillosis. Contributed by M Salahuddin, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ABPA." position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-72242.s10">
        <fig id="article-72242.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Asthma Severity Classification by The National Asthma Education and Prevention Program. Contributed by R Chabra, DO</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Classification" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-72242.s11">
        <title>References</title>
        <ref id="article-72242.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mannino</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Homa</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Akinbami</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Moorman</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Gwynn</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Redd</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Surveillance for asthma--United States, 1980-1999.</article-title>
            <source>MMWR Surveill Summ</source>
            <year>2002</year>
            <month>Mar</month>
            <day>29</day>
            <volume>51</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-13</page-range>
            <pub-id pub-id-type="pmid">12420904</pub-id>
          </element-citation>
        </ref>
        <ref id="article-72242.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <collab>Centers for Disease Control and Prevention (CDC)</collab>
            <article-title>Vital signs: asthma prevalence, disease characteristics, and self-management education: United States, 2001--2009.</article-title>
            <source>MMWR Morb Mortal Wkly Rep</source>
            <year>2011</year>
            <month>May</month>
            <day>06</day>
            <volume>60</volume>
            <issue>17</issue>
            <fpage>547</fpage>
            <page-range>547-52</page-range>
            <pub-id pub-id-type="pmid">21544044</pub-id>
          </element-citation>
        </ref>
        <ref id="article-72242.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maio</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Baldacci</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Carrozzi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pistelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Angino</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Simoni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sarno</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cerrai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Martini</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fresta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Silvi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Di Pede</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Guerriero</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Viegi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Respiratory symptoms/diseases prevalence is still increasing: a 25-yr population study.</article-title>
            <source>Respir Med</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>110</volume>
            <fpage>58</fpage>
            <page-range>58-65</page-range>
            <pub-id pub-id-type="pmid">26614595</pub-id>
          </element-citation>
        </ref>
        <ref id="article-72242.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weiss</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Gold</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Gender differences in asthma.</article-title>
            <source>Pediatr Pulmonol</source>
            <year>1995</year>
            <month>Mar</month>
            <volume>19</volume>
            <issue>3</issue>
            <fpage>153</fpage>
            <page-range>153-5</page-range>
            <pub-id pub-id-type="pmid">7792116</pub-id>
          </element-citation>
        </ref>
        <ref id="article-72242.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burrows</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Martinez</surname>
                <given-names>FD</given-names>
              </name>
              <name>
                <surname>Halonen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Barbee</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Cline</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Association of asthma with serum IgE levels and skin-test reactivity to allergens.</article-title>
            <source>N Engl J Med</source>
            <year>1989</year>
            <month>Feb</month>
            <day>02</day>
            <volume>320</volume>
            <issue>5</issue>
            <fpage>271</fpage>
            <page-range>271-7</page-range>
            <pub-id pub-id-type="pmid">2911321</pub-id>
          </element-citation>
        </ref>
        <ref id="article-72242.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gilliland</surname>
                <given-names>FD</given-names>
              </name>
              <name>
                <surname>Islam</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Berhane</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gauderman</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>McConnell</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Avol</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Regular smoking and asthma incidence in adolescents.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2006</year>
            <month>Nov</month>
            <day>15</day>
            <volume>174</volume>
            <issue>10</issue>
            <fpage>1094</fpage>
            <page-range>1094-100</page-range>
            <pub-id pub-id-type="pmid">16973983</pub-id>
          </element-citation>
        </ref>
        <ref id="article-72242.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Camargo</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Willett</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Speizer</surname>
                <given-names>FE</given-names>
              </name>
            </person-group>
            <article-title>Prospective study of body mass index, weight change, and risk of adult-onset asthma in women.</article-title>
            <source>Arch Intern Med</source>
            <year>1999</year>
            <month>Nov</month>
            <day>22</day>
            <volume>159</volume>
            <issue>21</issue>
            <fpage>2582</fpage>
            <page-range>2582-8</page-range>
            <pub-id pub-id-type="pmid">10573048</pub-id>
          </element-citation>
        </ref>
        <ref id="article-72242.r8">
          <label>8</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Chaudhry</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bordoni</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <chapter-title>Anatomy, Thorax, Lungs</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>24</day>
            <pub-id pub-id-type="pmid">29262068</pub-id>
          </element-citation>
        </ref>
        <ref id="article-72242.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patwa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Anatomy and physiology of respiratory system relevant to anaesthesia.</article-title>
            <source>Indian J Anaesth</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>59</volume>
            <issue>9</issue>
            <fpage>533</fpage>
            <page-range>533-41</page-range>
            <pub-id pub-id-type="pmid">26556911</pub-id>
          </element-citation>
        </ref>
        <ref id="article-72242.r10">
          <label>10</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Amador</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Varacallo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <chapter-title>Anatomy, Thorax, Bronchial</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">30726038</pub-id>
          </element-citation>
        </ref>
        <ref id="article-72242.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grinnan</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Truwit</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Clinical review: respiratory mechanics in spontaneous and assisted ventilation.</article-title>
            <source>Crit Care</source>
            <year>2005</year>
            <month>Oct</month>
            <day>05</day>
            <volume>9</volume>
            <issue>5</issue>
            <fpage>472</fpage>
            <page-range>472-84</page-range>
            <pub-id pub-id-type="pmid">16277736</pub-id>
          </element-citation>
        </ref>
        <ref id="article-72242.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Hubbard</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Proud</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Stealey</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Galli</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Kagey-Sobotka</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bleecker</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Lichtenstein</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes.</article-title>
            <source>Am Rev Respir Dis</source>
            <year>1991</year>
            <month>Jul</month>
            <volume>144</volume>
            <issue>1</issue>
            <fpage>51</fpage>
            <page-range>51-8</page-range>
            <pub-id pub-id-type="pmid">2064141</pub-id>
          </element-citation>
        </ref>
        <ref id="article-72242.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Homer</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Geba</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Elias</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production.</article-title>
            <source>J Clin Invest</source>
            <year>1999</year>
            <month>Mar</month>
            <volume>103</volume>
            <issue>6</issue>
            <fpage>779</fpage>
            <page-range>779-88</page-range>
            <pub-id pub-id-type="pmid">10079098</pub-id>
          </element-citation>
        </ref>
        <ref id="article-72242.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stewart</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Tomlinson</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Fernandes</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Tumor necrosis factor alpha modulates mitogenic responses of human cultured airway smooth muscle.</article-title>
            <source>Am J Respir Cell Mol Biol</source>
            <year>1995</year>
            <month>Jan</month>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>110</fpage>
            <page-range>110-9</page-range>
            <pub-id pub-id-type="pmid">7529028</pub-id>
          </element-citation>
        </ref>
        <ref id="article-72242.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doeing</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Solway</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Airway smooth muscle in the pathophysiology and treatment of asthma.</article-title>
            <source>J Appl Physiol (1985)</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>114</volume>
            <issue>7</issue>
            <fpage>834</fpage>
            <page-range>834-43</page-range>
            <pub-id pub-id-type="pmid">23305987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-72242.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brannan</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Lougheed</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Airway hyperresponsiveness in asthma: mechanisms, clinical significance, and treatment.</article-title>
            <source>Front Physiol</source>
            <year>2012</year>
            <volume>3</volume>
            <fpage>460</fpage>
            <pub-id pub-id-type="pmid">23233839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-72242.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chapman</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Irvin</surname>
                <given-names>CG</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of airway hyper-responsiveness in asthma: the past, present and yet to come.</article-title>
            <source>Clin Exp Allergy</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>45</volume>
            <issue>4</issue>
            <fpage>706</fpage>
            <page-range>706-19</page-range>
            <pub-id pub-id-type="pmid">25651937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-72242.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kudo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ishigatsubo</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Aoki</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Pathology of asthma.</article-title>
            <source>Front Microbiol</source>
            <year>2013</year>
            <month>Sep</month>
            <day>10</day>
            <volume>4</volume>
            <fpage>263</fpage>
            <pub-id pub-id-type="pmid">24032029</pub-id>
          </element-citation>
        </ref>
        <ref id="article-72242.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Limb</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Wood</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wise</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Eggleston</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Tonascia</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Adkinson</surname>
                <given-names>NF</given-names>
              </name>
            </person-group>
            <article-title>Irreversible lung function deficits in young adults with a history of childhood asthma.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>116</volume>
            <issue>6</issue>
            <fpage>1213</fpage>
            <page-range>1213-9</page-range>
            <pub-id pub-id-type="pmid">16337448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-72242.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <collab>National Asthma Education and Prevention Program</collab>
            <article-title>Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2007</year>
            <month>Nov</month>
            <volume>120</volume>
            <issue>5 Suppl</issue>
            <fpage>S94</fpage>
            <page-range>S94-138</page-range>
            <pub-id pub-id-type="pmid">17983880</pub-id>
          </element-citation>
        </ref>
        <ref id="article-72242.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buels</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Fryer</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>Muscarinic receptor antagonists: effects on pulmonary function.</article-title>
            <source>Handb Exp Pharmacol</source>
            <year>2012</year>
            <issue>208</issue>
            <fpage>317</fpage>
            <page-range>317-41</page-range>
            <pub-id pub-id-type="pmid">22222705</pub-id>
          </element-citation>
        </ref>
        <ref id="article-72242.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moore</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>de Waal Malefyt</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Coffman</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>O'Garra</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Interleukin-10 and the interleukin-10 receptor.</article-title>
            <source>Annu Rev Immunol</source>
            <year>2001</year>
            <volume>19</volume>
            <fpage>683</fpage>
            <page-range>683-765</page-range>
            <pub-id pub-id-type="pmid">11244051</pub-id>
          </element-citation>
        </ref>
        <ref id="article-72242.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D'Amato</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vitale</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Molino</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lanza</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>D'Amato</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Anticholinergic drugs in asthma therapy.</article-title>
            <source>Curr Opin Pulm Med</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>103</fpage>
            <page-range>103-108</page-range>
            <pub-id pub-id-type="pmid">27820743</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
